Showing 1981-1990 of 8891 results for "".
Teledermatology Update
https://practicaldermatology.com/topics/practice-management/teledermatology-update/20146/Many dermatologists and dermatologic surgeons adopted teledermatology or began to use it more frequently throughout the COVID pandemic. Many consultations and post-operative follow-up appointments were handled through telemedicine platforms. Anthony Rossi, MD talks about the benefits of this technolEstrogen and Skin: What Can We Do
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/estrogen-and-skin-what-can-we-do/20123/There’s accumulated evidence that depletion of estrogen with age contributes to the visible signs of skin aging. But dermatologists haven’t had many treatment options—until now. Joel L. Cohen, MD addresses the latest developments in care for estrogen deficient skin.The Roots of Dermatology
https://practicaldermatology.com/topics/practice-management/the-roots-of-dermatology/18355/The roots of dermatology run deep. The specialty formed in Europe, but Americans soon took a leading role in shaping the future of the field. This first of four episodes explores the early days of the specialty and takes stock of dermatology today.Clinical Conversations: MOA of JAK Inhibitors in Dermatology
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-moa-of-jak-inhibitors-in-dermatology/20096/JAK inhibitors have a range of potential applications in clinical dermatology. In the first video of this series, Brad Glick, DO and Raj Chovatiya, MD explain the mechanism of action of JAK inhibitors and explain how they may be used topically or systemically to treat skin diseases like atopic dermaAn Update on Neuromodulators and Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/an-update-on-neuromodulators-and-fillers/19983/Suneel Chilukuri, MD discusses daxibotulinumtoxinA and its potential for longer lasting results. He also reviews newly available fillers and specific options for various areas of the face. Plus, he talks about low-cost options and how he’s using devices like SkinPen.Patients types that may be a great fit for ILUMYA™
https://practicaldermatology.com/topics/psoriasis/patients-types-that-may-be-a-great-fit-for-ilumya/19859/See how ILUMYA™ is a treatment option for a diverse range of patients with moderate-to-severe plaque psoriasis, including bio-naive and bio-experienced patients, and those aged 65 years or older.Troubleshooting teledermatology
https://practicaldermatology.com/topics/practice-management/troubleshooting-teledermatology/19854/Doctors and patients alike praise the ability of technology to enable virtual care, but this rapid transition has not been entirely trouble-free. In this video from Ekwa Marketing, we look at some of the most common problems, and how you might be able to avoid or solve them.DERM2020 NP/PA CME Conference Thank You from DEF President Joe Gorelick, MSN, FNP-C
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-nppa-cme-conference-thank-you/19837/Joe Gorelick thanks the participants for DERM2020 Session 1 – all live webinars from August 6 – 11, 2020!Scientifically Speaking: Botulinum Toxin Formulation and Testing
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-botulinum-toxin-formulation-and-testing/19832/Ever wonder about the differences in formulation and manufacture of botulinum neurotoxins? Curious about the trials that support approval? In this edition of Scientifically Speaking, Joel L. Cohen, MD gets the answers to these questions and more from Conor Gallagher, PhD, Head of Medical Affairs, ReDermWireTV: Dermatology Moves Beyond the COVID-19 Crisis
https://practicaldermatology.com/topics/practice-management/dermwiretv-dermatology-moves-beyond-the-covid-19-crisis/19815/This special edition of DermWireTV takes a look at the dermatology space as offices reopen. Includes updates on disease spread from WHO, advice on PCR and antibody testing, as well as tips for reopening from Suneel Chilukuri, MD (Refresh Dermatology) and Kimberly Campbell. Plus, Amy Forman Taub, MD